Outsourcing Industry Marked by Considerable Investments in 2016

June 15, 2016

BioPharm International

Volume 2016 ebook, Issue 1

Page Number: 39–41

Biopharmaceutical contractors continue to invest in development, facility upgrades, technological advancement, and mergers and acquisitions.

The biopharmaceutical outsourcing industry has been marked by investment in technology and facility upgrades, mergers, acquisitions, and development partnerships in 2016. This article details are some of the latest developments in the biopharmaceutical outsourcing market.

Download the

.